After-Hours Stock Movers 10/06: (GPS) (CIT) (DVAX) Higher; (MG) (RT) (HON) Lower (more...)

October 6, 2016 6:02 PM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Today's After-Hours Movers

Mistras Group, Inc. (NYSE: MG) 7.2% LOWER; reported Q1 EPS of $0.22, $0.02 better than the analyst estimate of $0.20. Revenue for the quarter came in at $168.4 billion, versus $179.9 billion reported last year. GUIDANCE: Mistras Group, Inc. sees FY2017 EPS of $0.88-$0.97, versus prior guidance of $0.99-$1.12. Mistras Group, Inc. sees FY2017 revenue of $690-705 million, versus prior guidance of $720-735 million.

Gap (NYSE: GPS) 6% HIGHER; September 2016 comparable sales by approximately 3%, which was better than expected.

CIT Group Inc. (NYSE: CIT) 5.8% HIGHER; announced that it has entered into a definitive agreement to sell CIT Commercial Air, its commercial aircraft leasing business, to Avolon Holdings Limited (Avolon), the international aircraft leasing company and a wholly-owned subsidiary of Bohai Capital Holding Co. Ltd. The transaction is expected to close by the end of the first quarter of 2017, subject to regulatory approvals and customary closing conditions.

Ruby Tuesday (NYSE: RT) 5.2% LOWER; reported Q1 EPS of ($0.11), versus ($0.03) reported last year. Revenue for the quarter came in at $256.7 million, versus $279.48 million reported last year.

Dynavax Technologies (NASDAQ: DVAX) 4% HIGHER; Steven Cohen's Point72 Asset Management, L.P. disclosed a 5.9%, or 2,280,608 share, stake in the company.

Honeywell (NYSE: HON) 3% LOWER; updates guidance.

Helen of Troy (NASDAQ: HELE) 2.7% LOWER; reported Q2 EPS of $1.31, $0.17 better than the analyst estimate of $1.14. Revenue for the quarter came in at $368.2 million versus the consensus estimate of $143.88 million. Helen of Troy reaffirmed FY2016 EPS guidance. For fiscal year 2017, the Company now expects consolidated net sales revenue in the range of $1.550 to $1.590 billion, versus prior guidance of $1.570 to $1.620 billion.

AxoGen, Inc. (Nasdaq: AXGN) 1.7% LOWER; announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Synergy Pharma (NASDAQ: SGYP) 1.5% LOWER; filed to offer 3,126,795 shares for holders.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

SAC Capital, Steven A. Cohen, After-Hours Movers, Point72 Asset

Add Your Comment